These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26224081)

  • 1. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
    Song L; Liu S; Zeng S; Zhang L; Li X
    Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145.
    Lu H; He Y; Lin L; Qi Z; Ma L; Li L; Su Y
    Tumour Biol; 2016 Feb; 37(2):1683-91. PubMed ID: 26311052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1.
    Liu S; Song L; Zhang L; Zeng S; Gao F
    Biochem Biophys Res Commun; 2015 Apr; 459(4):679-85. PubMed ID: 25769949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
    Geng D; Song X; Ning F; Song Q; Yin H
    Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
    Liu S; Song L; Zeng S; Zhang L
    Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer.
    Zhang M; Song Y; Zhai F
    J Cell Biochem; 2018 Jun; 119(6):4397-4407. PubMed ID: 29130509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
    Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
    Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
    Shi M; Du L; Liu D; Qian L; Hu M; Yu M; Yang Z; Zhao M; Chen C; Guo L; Wang L; Song L; Ma Y; Guo N
    J Pathol; 2012 Oct; 228(2):148-57. PubMed ID: 22287315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
    Zhang J; Wang L; Jiang J; Qiao Z
    Cell Cycle; 2020 Mar; 19(6):652-665. PubMed ID: 32126879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis.
    Liu S; Pan X; Yang Q; Wen L; Jiang Y; Zhao Y; Li G
    Oncol Rep; 2015 Jun; 33(6):2853-62. PubMed ID: 25963391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.
    Wu Y; Huang J; Xu H; Gong Z
    Biomed Pharmacother; 2018 Sep; 105():1325-1334. PubMed ID: 30021370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
    Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
    Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.
    Wang X; Li Q; Jin H; Zou H; Xia W; Dai N; Dai XY; Wang D; Xu CX; Qing Y
    Oncotarget; 2016 Nov; 7(47):77508-77515. PubMed ID: 27769049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
    Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
    Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
    Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
    Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.
    Yuan W; Xiaoyun H; Haifeng Q; Jing L; Weixu H; Ruofan D; Jinjin Y; Zongji S
    Int J Med Sci; 2014; 11(7):691-6. PubMed ID: 24843318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
    Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X
    Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.